Bio-Techne Quarterly Balance Sheet
NASDAQ: TECHHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bio-Techne financial position
As of Jun 30, 2026, Bio-Techne reported total assets of $2.59 billion, up 1.1% from a year earlier against total liabilities of $478.5 million. Shareholders' equity stood at $2.11 billion, or 81.5% of assets. The company held $264.7 million in cash and equivalents against $200.0 million of debt, a net cash position of $64.7 million.
The current ratio (current assets divided by current liabilities) was 4.55, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.09.
Summary generated from market data by MetaCap's automated system. Methodology
Bio-Techne balance sheet (quarterly)
| Quarter (USD) | Q4 20262026-06-30 | Q3 20262026-03-31 | Q2 20262025-12-31 | Q1 20262025-09-30 | Q4 20252025-06-30 | Q3 20252025-03-31 | Q2 20252024-12-31 | Q1 20252024-09-30 | Q4 20242024-06-30 | Q3 20242024-03-31 | Q2 20242023-12-31 | Q1 20242023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 264.71M | 209.82M | 172.88M | 144.96M | 162.19M | 140.67M | 177.55M | 187.54M | 151.79M | 139.91M | 130.13M | 148.66M |
| Short-Term Investments | — | — | — | — | — | 0 | 0 | — | 1.07M | 5.40M | 5.52M | — |
| Receivables | 216.59M | 214.56M | 184.61M | 183.90M | 206.88M | 237.14M | 217.94M | 223.69M | 241.39M | 227.89M | 207.45M | 204.57M |
| Inventory | 195.74M | 201.18M | 205.45M | 203.19M | 189.45M | 191.08M | 188.37M | 185.04M | 179.73M | 179.50M | 180.84M | 186.08M |
| Total Current Assets | 744.40M | 688.05M | 637.43M | 609.51M | 608.30M | 627.24M | 634.64M | 648.57M | 617.42M | 610.65M | 590.64M | 591.48M |
| Property, Plant & Equipment | 231.84M | 232.99M | 234.38M | 240.33M | 245.72M | 251.98M | 249.75M | 253.94M | 251.15M | 243.73M | 234.20M | 231.68M |
| Goodwill | 975.36M | 977.80M | 980.56M | 978.91M | 980.93M | 968.61M | 964.61M | 982.59M | 972.66M | 970.97M | 980.08M | 969.38M |
| Intangible Assets | 303.46M | 319.07M | 334.99M | 350.11M | 365.60M | 443.70M | 461.05M | 486.00M | 507.08M | 526.43M | 550.61M | 578.97M |
| Total Assets | 2.59B | 2.55B | 2.52B | 2.53B | 2.56B | 2.64B | 2.67B | 2.74B | 2.70B | 2.72B | 2.73B | 2.76B |
| Accounts Payable | 26.70M | 23.49M | 26.27M | 30.16M | 25.31M | 31.64M | 33.12M | 31.56M | 37.97M | 28.89M | 31.51M | 28.08M |
| Total Current Liabilities | 163.70M | 153.28M | 140.43M | 144.54M | 175.85M | 169.20M | 161.26M | 142.13M | 159.38M | 149.82M | 135.23M | 127.75M |
| Long-Term Debt | 200.00M | 200.00M | 260.00M | 300.00M | 346.00M | 330.00M | 300.00M | 300.00M | 319.00M | 389.00M | 447.00M | 440.00M |
| Total Liabilities | 478.50M | 465.30M | 511.71M | 560.33M | 639.06M | 626.23M | 591.93M | 597.37M | 635.02M | 706.79M | 767.19M | 757.61M |
| Shareholders' Equity | 2.11B | 2.09B | 2.01B | 1.97B | 1.92B | 2.02B | 2.08B | 2.14B | 2.07B | 2.01B | 1.96B | 2.00B |
| Retained Earnings | 1.14B | 1.15B | 1.11B | 1.08B | 1.07B | 1.20B | 1.29B | 1.34B | 1.33B | 1.30B | 1.26B | 1.33B |
| Total Debt | 200.00M | 200.00M | 260.00M | 300.00M | 346.00M | 330.00M | 300.00M | 300.00M | 319.00M | 389.00M | 447.00M | 440.00M |
| Net Cash (Debt) | 64.71M | 9.82M | -87.12M | -155.04M | -183.81M | -189.33M | -122.45M | -112.46M | -166.14M | -243.69M | -311.35M | -291.34M |
| Shares Outstanding | 156.10M | 156.52M | 155.88M | 155.75M | 154.97M | 156.76M | 157.92M | 158.88M | 158.22M | 157.55M | 157.14M | 158.35M |
This table shows 12 quarterly periods of Bio-Techne's balance sheet, from Q4 2026 back to Q1 2024, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow TECH's reporting calendar. What is a balance sheet?